Position in BHVN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,978,428
+$913,976 QoQ
Shares Held
132,959
+5.7% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 294 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in BHVN Over Time
Shares Held
Position Value (USD)
Derivatives in BHVN
reported options exposure · as of Dec 31, 2025CallValue
$1,129
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. BHVN ranks #76 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in BHVN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,978,428 | 132,959 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,064,452 | 125,822 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,129 | 100 | Call | Sole | 2026-02-13 | |
| 2025-12-31 | $3,622,351 | 320,846 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,585,056 | 105,600 | Put | Sole | 2026-03-31 | |
| 2025-09-30 | $6,317,709 | 420,900 | Call | Sole | 2026-03-31 | |
| 2025-09-30 | $5,206,126 | 346,844 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $4,898,468 | 347,163 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $3,933,375 | 163,618 | Shares | Defined | 2026-03-17 | |
| 2024-12-31 | $14,668,352 | 392,727 | Shares | Defined | 2026-03-19 | |
| 2024-09-30 | $13,395,806 | 268,077 | Shares | Defined | 2026-03-31 | |
| 2024-06-30 | $4,959,642 | 142,888 | Shares | Defined | 2026-03-23 | |
| 2024-03-31 | $4,699,730 | 85,934 | Shares | Defined | 2026-03-24 | |
| 2023-12-31 | $9,711,448 | 226,903 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $3,852,000 | 90,000 | Call | Sole | 2026-03-24 | |
| 2023-09-30 | $4,575,497 | 175,913 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $2,678,322 | 111,970 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $1,950,470 | 142,787 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $2,721,423 | 196,068 | Shares | Sole | 2026-03-30 | |
| No filing history on record for this holder in this stock. | ||||||